Moderna experimental personalized cancer vaccine reduced the risk of relapse or death from melanoma when combined with Merck Keytruda in a mid-stage trial, a key step in expanding the use of messenger RNA technology beyond COVID-19 prevention.
Moderna Inc.’s experimental personalized cancer vaccine reduced the risk of relapse or death from melanoma when combined with Merck & Co.’s Keytruda in a mid-stage trial, a key step in expanding the use of messenger RNA technology beyond COVID-19 prevention.
The results provide the first real evidence of benefit for an mRNA cancer therapy, but the results of the study also suggest “a limited number of events or lack of effect in a subgroup of patients,” Bloomberg Intelligence analyst Sam Fazeli wrote. To make the vaccine, Moderna takes a biopsy of a tumor, isolates some of the proteins and integrates them into a vaccine that teaches the immune system to recognize those markers. That helps the body fight the cancer if or when it returns.Researchers have been working on personalized cancer vaccines for decades with only limited success, not least because they’re hard to manufacture on a large scale.
Moderna believes it now has enough data to test its vaccine in other types of cancers, Chief Executive Officer Stéphane Bancel said in an interview with Bloomberg Television.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck, Moderna detail potential skin cancer vaccine progressShares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study.
Read more »
Saskatoon sees COVID-19 wastewater viral load increase after several decreases | Globalnews.caSaskatoon saw its first increase after three successive decreases, with the RNA load increasing 148.8 per cent for the reporting period up to Dec. 7.
Read more »
Merck, Moderna detail potential skin cancer vaccine progressShares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study.
Read more »
Stocks, U.S. futures advance as traders await CPI - BNN BloombergU.S. index futures and European equities rose amid forecasts inflation in the world's largest economy will post the lowest figure this year, warranting a less hawkish Federal Reserve.
Read more »
'Incredible challenges': Shopify president talks pandemic, stock plunge and layoffs - BNN BloombergWhen the COVID-19 pandemic began and brick-and-mortar stores closed businesses flocked to Shopify. The problem? Consumers weren’t forgoing in-person shopping for good, skewing Shopify's forecasts.
Read more »
P.E.I. man gets jail for drug impaired driving | SaltWireCHARLOTTETOWN, P.E.I. — A Charlottetown man who drove while impaired by a combination of drugs, including fentanyl and methamphetamine, and nearly struck ...
Read more »